Corcept Therapeutics Files 2024 10-K
Ticker: CORT · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1088856
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Corcept's 2024 10-K is in. Shows financials from 2021-2024. Check it out.
AI Summary
Corcept Therapeutics Inc. filed its 2024 10-K on February 26, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, based in Redwood City, CA, operates in the pharmaceutical preparations sector. Key personnel mentioned include Joseph K. Belanoff, M.D., and William Guyer. The filing covers financial data for the years 2021 through 2024, including details on common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides a comprehensive overview of Corcept Therapeutics' financial health and operational details for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Corcept Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K filing.)
- 2021-2024 — Financial Data Range (Covers multiple years of financial performance.)
Key Players & Entities
- CORCEPT THERAPEUTICS INC (company) — Filer
- 20241231 (date) — Fiscal Year End
- 20250226 (date) — Filing Date
- Redwood City, CA (location) — Business Address
- Joseph K. Belanoff, M.D. (person) — Member
- William Guyer (person) — Member
FAQ
What were Corcept Therapeutics' total revenues for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is the company's primary business segment?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Who are the key individuals mentioned in the filing?
Joseph K. Belanoff, M.D., and William Guyer are mentioned as members.
When was this 10-K filing submitted to the SEC?
The filing was submitted on February 26, 2025.
What is the company's state of incorporation?
The company is incorporated in Delaware (DE).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 by Joseph K. Belanoff, M.D. regarding CORCEPT THERAPEUTICS INC (CORT).